Author:
Berg Michel J.,Gross Robert A.,Haskins Lisa S.,Zingaro Wendy M.,Tomaszewski Kenneth J.
Subject
Behavioral Neuroscience,Clinical Neurology,Neurology
Reference20 articles.
1. Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997–2000;Haas;Ann Intern Med,2005
2. The debate over substitution policy: its evolution and scientific basis;Schwartz;Am J Med,1985
3. Center for Drug Evaluation and Research (CDER). Immediate release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls, in vitro dissolution testing, and in vivo bioequivalence documentation. 1995. Available at:http://www.fda.gov/cder/guidance/cmc5.pdf.
4. Generic substitution for brand name antiepileptic drugs: a survey;Guberman;Can J Neurol Sci,2000
5. Are there potential problems with generic substitution of antiepileptic drugs?;Crawford;A review of issues. Seizure,2006
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献